Journal ArticleOPEN ACCESS

Enzymatic Catalysts to Combat COVID-19

ACS Central Science (2021) 7(12) 1963-1965
DOI: 10.1021/acscentsci.1c01356
6Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Enzyme engineering provides a scalable route to molnupavir, an orally bioavailable small molecule with therapeutic efficacy against COVID-19.

Cite

CITATION STYLE

APA

Jhulki, I., & Meier, J. L. (2021). Enzymatic Catalysts to Combat COVID-19. ACS Central Science, 7(12), 1963–1965. https://doi.org/10.1021/acscentsci.1c01356

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free